Mitchell W Thomas

Neurocrine Biosciences Inc.

Director

Avg. Two Year Performance

(65%) Avg. Purchase Return (28%) Compound

(34%) Avg. Sale Return (16%) Compound

Holdings: 1.0K shares

Last Three Months: 24-Aug-24 -- 23-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

24-Nov-22 -- 23-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions